A2M receives US FDA approval to import infant milk formula products into the US

Nov 03, 2022

The a2 Milk Company (ASX: A2M) announced that US Food and Drug Administration (FDA) has informed A2M that it has exercised its discretion to allow A2M to import infant milk formula products into the United States.

Following the start of IMF supply disturbance in the US, FDA Guidance was released regarding case-by-case consideration of enforcement discretion to be applied to businesses with the objective of increasing infant milk formula supplies.

On 26 May 2022, the Company applied to the US FDA under its enforcement discretion to supply infant milk formula to the US. However, on 10 August 2022, FDA deferred further consideration of the Company’s application for enforcement discretion. However, A2M continued to engage with the FDA to fulfil its requirements and to think again A2M’s application.

After all these, A2M today received confirmation from the FDA to import its import infant milk formula.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au